First Patient Enrolled in Diffusion Pharmaceuticals’ Phase 2 On-Ambulance Clinical Trial with TSC for the Treatment of Stroke


You May Also Like

Momenta Pharmaceuticals Announces Date for Second Quarter 2016 Financial Results Conference Call and Webcast

CAMBRIDGE, Mass., July 21, 2016 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA), a biotechnology ...

Diffusion Pharmaceuticals Appoints Thomas Byrne as General Counsel

CHARLOTTESVILLE, Va., April 01, 2016 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (OTCQX:DFFN), a clinical ...